McGill Centre for the Prevention of Cardiovascular Disease
The MUHC’s strategy for assessing heart disease is radically different than the conventional model used today. Our Benefit Model and new technologies such as apoB testing are leading the way globally in changing the prevention paradigm for cardiovascular disease.Dr. Allan Sniderman
Every seven minutes, a Canadian dies from heart disease, making it the most common cause of death in our country. 90% of Canadians have at least one risk factor associated with the disease and more than 350,000 Canadians are hospitalized for heart disease each year.
Cardiovascular disease (CVD) can have a significant physical, emotional and financial impact on patients and their families including: serious disability, the development of anxiety or depression and potential loss of income as a result of an illness. Better efforts related to prevention need to be made before the disease claims the life of another father, mother, daughter, or brother and sister.
Currently, the conventional model of cardiovascular prevention is based on treating those who are at high risk of cardiovascular disease. The model targets those who have already suffered a cardiovascular event such as a heart attack or stroke or those who are at high risk of a cardiovascular event within the next 10 years. These programs are effective but they are limited in what they can accomplish because, too often, they start too late.
The MUHC bases its CVD assessment on benefit and not just risk. The hospital has implemented the Benefit Model among its clinical practice, which incorporates and extends the traditional “risk model” by treating younger people who have a greater opportunity to benefit from statin treatments, a type of therapy that lowers the level of cholesterol in the blood by reducing the production of cholesterol by the liver. By using this new treatment strategy, the number of people who will be eligible to be screened for heart disease will greatly increase, which will ultimately lower the incidence of CVD in men and women.
To bring the MUHC one step closer to leading the worldwide effort to better prevent and treat cardiovascular disease, a McGill Centre for the Prevention of Cardiovascular Disease is being developed that will:
- Ensure that women and men are screened earlier before a potential CVD event occurs, which will help save more lives
- Establish a more accurate prevention model to better determine the incidence of CVD
- Build a collaborative network of international medical experts to foster new techniques in cardiovascular disease prevention
- Purchase leading-edge technology and equipment to launch complex cardiovascular research projects more quickly and efficiently
How you can help
We are raising $5 million to support the creation of the McGill Centre for the Prevention of Cardiovascular Disease.